J Investig Allergol Clin Immunol. 2024 Jun;34(3):214-216. doi: 10.18176/jiaci.0990.
NO ABSTRACT
PMID:38888584 | DOI:10.18176/jiaci.0990
Successful Desensitization to Isatuximab in a Patient With Refractory Multiple Myeloma and Indolent Systemic Mastocytosis. Reply to: Anaphylactic Shock due to Isatuximab and Successful Desensitization
by | Jun 18, 2024 | Publications | 0 comments